CML · Oncology · 3 drugs · 3 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Scemblix | NVS | BCR-ABL inhibitor (STAMP) | Small molecule | Oral | APPROVED |
| Tasigna | NVS | BCR-ABL inhibitor (STAMP) | Small molecule | Oral | APPROVED |
| Iclusig | — | BCR-ABL inhibitor (pan) | Small molecule | PO | APPROVED |